Similar articles

• Respecting participant autonomy and the disclosure of clinical trial results.

  Oakley J. Oakley J. Am J Bioeth. 2009 Aug;9(8):38. doi: 10.1080/15265160902979806. Am J Bioeth. 2009. PMID: 19998158 No abstract available.
• Disclosing clinical trial results: publicity, significance and independence.

  Liao SM, Sheehan M, Clarke S. Liao SM, et al. Am J Bioeth. 2009 Aug;9(8):W3-5. doi: 10.1080/15265160903088151. Am J Bioeth. 2009. PMID: 19998144 No abstract available.
• Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?

  Vernillo A. Vernillo A. Am J Bioeth. 2009 Aug;9(8):45-7. doi: 10.1080/15265160902939933. Am J Bioeth. 2009. PMID: 19998162 No abstract available.
• Ethical considerations.

  Treiman DM. Treiman DM. Epilepsy Res Suppl. 1993;10:137-48. Epilepsy Res Suppl. 1993. PMID: 8251089 Review. No abstract available.
• Commercialism and medicine: an overview.

  Kassirer JP. Kassirer JP. Camb Q Healthc Ethics. 2007 Fall;16(4):377-86; discussion 439-42. doi: 10.1017/s0963180107070478. Camb Q Healthc Ethics. 2007. PMID: 18018917 Review. No abstract available.